(PDF) P1.15-27 Patient Characteristics, Treatment Patterns

P1.15-27 Patient Characteristics, Treatment Patterns and Survival for Unresectable Stage III NSCLC in Ontario, Canada

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.959

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

P1.15-28 Real World Treatment Patterns and Survival of Stage IV Non-Small Cell Lung Cancer (NSCLC) in Ontario, Canada

Journal of Thoracic Oncology

Respiratory Medicine

English

Pcn221 - Stage Iii Unresectable Non-Small Cell Lung Cancer Treatment Patterns and Costs: An Ontario, Canada Analysis

Value in Health

Occupational Health

English

P2.01-58 Demographics, Clinical Characteristics and Treatment Sequencing in Stage III Unresectable NSCLC Patients: A Cancerlinq Cohort

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.15-34 Treatment Patterns and Outcomes of Stage III Non-Small Cell Lung Cancer (NSCLC): Real World Evidence of How Our Patients Fare

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.17-04 Curative Intent Treatment for Stage III NSCLC in England

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-88 Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFRm-Positive Stage III NSCLC (LAURA)

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC With Atezolizumab + Chemotherapy

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.15-27 Initial Response to First Line Treatment Is the Best Predictor of the Patient Survival in Advanced NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.17-12 Phase II Trial of Atezolizumab Before and After Chemoradiation for Unresectable Stage III NSCLC (AFT-16): Trial in Progress

Journal of Thoracic Oncology

Respiratory Medicine

English